Sensitive ASX Announcement

Actinogen secures $4.3m of non-dilutive R&D tax funding

Published: 27/01/26, 09:02am (AEST)3 pages
Actinogen Medical
ACW:ASXHealthcare

Recent ACW Announcements

Price Sensitive only